ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir ...
EUR/USD struggles as ECB holds rates at 2.90%, while weak German data fuels growth concerns. Will the euro rebound or slide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback